The Telegraph: House prices fell unexpectedly last month as mortgage borrowers prepare for a jump in interest rates. Typical property values declined by 0.2pc during September, reversing 0.2pc growth in
RNS Hotlist with Zak Mir: INT, LFT, GWMO, UFO, COIL, REV, KLR, ENSI, FCM, CPH2 & TBTG
(Citywire) FCA looks at urgent review into unregulated advice given by AI: The Mills Review calls on the regulator to scrutinise unregulated advice given by AI platforms, which threatens to create
RNS Hotlist with Zak Mir: HALO, COIL, RCGH, ROAD, GEX, GRX, AXL, KDNC, GST, GEO, SWT, 80M, GMET, GROC & LIKE
Halo Minerals PLC (HALO), the copper development company focused on extracting critical minerals from legacy mining waste, announced the initiation of independent equity research coverage by Equity Development. The research
RNS Hotlist with Zak Mir: TGR, BKS, ACRM, DEBS, REVB, BUCE, BHLL, SSIT, COIL, PHE, ZEN, PREM, FORG, HEX, KEFI, APTA, CORA, GENI, BOOM, MAC, JAN, TYM, ASIC & GWMO
Total Graphite plc (TGR), the specialist flake graphite company developing an integrated graphite mine-to-materials supply chain for the global energy transition, announced that, following an advanced stage of the operational
Traders Cafe with Zak Mir: Bulletin Board Heroes, Weekend Edition, Sunday 24th May 2026
Zak Mir takes a charting look at some of the most closely followed small caps on the London Stock Exchange. Today’s charts are FTSE 100, DAX, Dow, Bitcoin, Ethereum, Gold, WTI
Traders Cafe with Zak Mir: Bulletin Board Heroes, Tuesday 19th May 2026
Zak Mir takes a charting look at some of the most closely followed small caps on the London Stock Exchange. Today’s charts are for the FTSE 100, DAX, Dow, Bitcoin, Ethereum,
Share Talk Weekly Stock Market News Review, Sunday 29th March 2026
The AIM All-Share slipped slightly on the week and is now down around 7% year-to-date, underlining the pressure on smaller companies. In contrast, the FTSE 100 closed the week at 9,967, slipping just 5
Coiled Therapeutics plc (AIM: COIL) Admission to Trading and First Day of Dealings
Clinical stage oncology company joins AIM